Botulinum toxin treatment for hyperhidrosis
HAYES, Inc.
Record ID 32006000088
English
Authors' objectives:
Botulinum toxin type A and B (BTX-A and BTX-B), neurotoxins produced by the bacterium Clostridium (C.) botulinum, are used to reduce excessive sweating associated with various forms of hyperhidrosis. The goal of injection of BTX-A or BTX-B at the affected site is to reduce excessive sweating by blocking the release of acetylcholine, thus interfering with nerve transmission at the autonomic nerve endings that innervate sweat glands.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Hyperhidrosis
- Botulinum Toxins
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.